Cargando…
COVID-19 Vaccination is Associated With Favorable Outcomes Among Lung Transplant Patients With Breakthrough Infections
BACKGROUND: There are limited data regarding the clinical efficacy of COVID-19 vaccines among lung transplant (LT) patients. METHODS: We included all LT patients diagnosed with COVID-19 between March 1, 2020, and December 10, 2021 (n = 84; median age 55, range, 20-73 years; males 65.5%). The study g...
Autores principales: | Bollineni, Srinivas, Mahan, Luke D., Lawrence, Adrian, Joerns, John, Timofte, Irina, Torres, Fernando, Kaza, Vaidehi, La Hoz, Ricardo M., SoRelle, Jeffrey A., Kershaw, Corey D., Terada, Lance S., Zhang, Song, Mohanka, Manish R., Banga, Amit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197779/ https://www.ncbi.nlm.nih.gov/pubmed/35909014 http://dx.doi.org/10.1016/j.transproceed.2022.05.030 |
Ejemplares similares
-
A Case Report of Breakthrough Infections With 2 SARS-CoV-2 Variants in a Lung Transplant Patient
por: Mahan, Luke D., et al.
Publicado: (2022) -
Clinical characteristics, management practices, and outcomes among lung transplant patients with COVID-19
por: Mohanka, Manish R., et al.
Publicado: (2021) -
Community-Acquired Respiratory Virus Infections During the First Year After Lung Transplantation
por: Mahan, Luke, et al.
Publicado: (2017) -
Significance of Best Spirometry in the First Year After Bilateral Lung Transplantation: Association With 3-Year Outcomes
por: Mohanka, Manish R., et al.
Publicado: (2019) -
2695. Lung Transplant Recipients With High Risk Cytomegalovirus Mismatch Donors Managed Using A Multimodality Regimen: A Five-Year Study
por: Banga, Amit, et al.
Publicado: (2023)